SUPPRELIN

Endo Pharmaceuticals Inc.🇺🇸 United States

FDA Page

Effective Date: Apr 27, 2022
Approval ID: d8fb000e-3cc9-4803-b71d-2cc597661977
Products: 1 registered
Version: 33

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use SUPPRELIN LA safely and effectively. See full prescribing information for LA. LA (histrelin acetate) subcutaneous implant Initial U.S. Approval: 1991

Quick Stats

Total Products1

Labelers2

Label Sections21

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.